Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000712542 | SCV000843057 | uncertain significance | not provided | 2017-11-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001049765 | SCV001213835 | likely benign | Multiple congenital anomalies-hypotonia-seizures syndrome 1 | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002388356 | SCV002698405 | uncertain significance | Inborn genetic diseases | 2020-03-04 | criteria provided, single submitter | clinical testing | The p.K475E variant (also known as c.1423A>G), located in coding exon 13 of the PIGN gene, results from an A to G substitution at nucleotide position 1423. The lysine at codon 475 is replaced by glutamic acid, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV000712542 | SCV004170604 | uncertain significance | not provided | 2023-07-26 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |